Detail akcie MPH Health Care Br online

Business Summary: MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
Financial Summary: BRIEF: For the six months ended 30 June 2025, MPH Health Care AG revenues increased from EUR13K to EUR35K. Net loss totaled EUR72.7M vs. income of EUR74.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Fair value gain on valuation of financia decrease of 94% to EUR5.5M (income), Fair value loss financial assets increase from EUR4.1M to EUR77.8M (expense).